98 related articles for article (PubMed ID: 289865)
1. Angiotensin II blockade: evidence for baroreceptor-mediated renin release and the role of sodium balance.
Baer L; Parra-Carrillo JZ; Radichevich I
Kidney Int Suppl; 1979 Mar; (9):S60-7. PubMed ID: 289865
[No Abstract] [Full Text] [Related]
2. Angiotensin II blockade by saralasin in the evaluation of hypertension in children.
Favre L; Boerth RC; Braren V; Dean RH; Hollifield JW
Kidney Int Suppl; 1979 Mar; (9):S75-82. PubMed ID: 289867
[No Abstract] [Full Text] [Related]
3. Hemodynamic correlates of saralasin: responsiveness in hypertension.
Kem DC; Frohlich ED; de Carvalho JG; Dunn FG; Chrysant SG; Danisa K; Wambach G
Kidney Int Suppl; 1979 Mar; (9):S68-74. PubMed ID: 289866
[No Abstract] [Full Text] [Related]
4. Angiotensin as a renal, adrenal, and cardiovascular hormone: responses to saralasin in normal man and in essential and secondary hypertension.
Hollenberg NK; Williams GH
Kidney Int Suppl; 1979 Mar; (9):S29-35. PubMed ID: 384070
[No Abstract] [Full Text] [Related]
5. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
Bing RF; Russell GI; Swales JD; Thurston H
J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
[TBL] [Abstract][Full Text] [Related]
6. Saralasin in human hypertension: the early experience.
Brunner HR; Laragh JH
Kidney Int Suppl; 1979 Mar; (9):S36-43. PubMed ID: 289862
[No Abstract] [Full Text] [Related]
7. Outpatient experience with saralasin.
Streeten DH; Anderson GH
Kidney Int Suppl; 1979 Mar; (9):S44-52. PubMed ID: 289863
[No Abstract] [Full Text] [Related]
8. Angiotensin II blockade in normal man and patients with essential hypertension. Blood pressure effects depending on renin and sodium balance.
Brunner HR; Gavras H; Ribeiro AB; Posternak L
Prog Biochem Pharmacol; 1976; 12():145-62. PubMed ID: 1019161
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin blockade by saralasin bolus injection.
Maxwell MH; Marks LS
Kidney Int Suppl; 1979 Mar; (9):S53-9. PubMed ID: 289864
[No Abstract] [Full Text] [Related]
10. Drug interactions with saralasin.
Mitchell HC; Keeton TK; Pettinger WA
Kidney Int Suppl; 1979 Mar; (9):S101-6. PubMed ID: 289859
[TBL] [Abstract][Full Text] [Related]
11. Comparison of renal vein renin activity in hypertensive patients with stenosis of one or both renal arteries.
Pickering TG; Sos TA; James GD; Vaughan ED; Sealey JE; Laragh JH
J Hypertens Suppl; 1985 Dec; 3(3):S291-3. PubMed ID: 2856720
[TBL] [Abstract][Full Text] [Related]
12. [Renovascular hypertension: prediction of surgical treatment by angiotensin II blockade and saralasin (author's transl)].
Mimran A; Deschodt G; Barjon P; Mary H; Thevenet A
Nouv Presse Med; 1978 Dec; 7(43):3889-93. PubMed ID: 733540
[TBL] [Abstract][Full Text] [Related]
13. The role of the renin-angiotensin system in hypertension.
Robertson JI
Semin Nephrol; 1988 Jun; 8(2):120-30. PubMed ID: 3293136
[No Abstract] [Full Text] [Related]
14. Saralasin infusion in renovascular and essential hypertension.
Thien T; Hoefnagels WH
Neth J Med; 1980; 23(2):68-73. PubMed ID: 6990282
[No Abstract] [Full Text] [Related]
15. The pathophysiology of renin release in renovascular hypertension.
Welch WJ
Semin Nephrol; 2000 Sep; 20(5):394-401. PubMed ID: 11022891
[TBL] [Abstract][Full Text] [Related]
16. Role of the renin-angiotensin system in renal hypertension. An experimental approach.
Helmchen U; Kneissler U
Curr Top Pathol; 1976; 61():203-38. PubMed ID: 1248262
[No Abstract] [Full Text] [Related]
17. Reactive hyperreninemia in renovascular hypertension after angiotensin blockage with saralasin or converting enzyme inhibitor.
Case DB; Laragh JH
Ann Intern Med; 1979 Aug; 91(2):153-60. PubMed ID: 464461
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic probes to identify patients with renovascular hypertension.
Sosa RE; Vaughan ED
Semin Urol; 1985 Nov; 3(4):317-24. PubMed ID: 2887024
[TBL] [Abstract][Full Text] [Related]
19. Renin, sodium, and vasodepressor response to saralasin in renovascular and essential hypertension.
Marks LS; Maxwell MH; Kaufman JJ
Ann Intern Med; 1977 Aug; 87(2):176-82. PubMed ID: 889198
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin antagonists as diagnostic and pharmacologic tools.
Pettinger WA; Mitchell HC
Prog Biochem Pharmacol; 1976; 12():203-13. PubMed ID: 798203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
